Assignee
AXSOME MALTA LTD
MT·35 granted patents·16 pending applications·50 citations·filing 2020–2025
Top patents by PatentIndex Score
51 records- 0198US11771666B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2022·Granted Oct 3, 2023·3 cites·21 claims
- 0298US11771667B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Oct 3, 2023·4 cites·26 claims
- 0397US11986455B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted May 21, 2024·2 cites·24 claims
- 0497US11969404B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted Apr 30, 2024·2 cites·18 claims
- 0597US11872204B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Jan 16, 2024·2 cites·16 claims
- 0697US11872203B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Jan 16, 2024·2 cites·18 claims
- 0797US11857528B1Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted Jan 2, 2024·2 cites·26 claims
- 0897US11850227B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted Dec 26, 2023·2 cites·25 claims
- 0997US11850228B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted Dec 26, 2023·2 cites·25 claims
- 1097US11850226B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted Dec 26, 2023·2 cites·12 claims
- 1197US11839598B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted Dec 12, 2023·2 cites·15 claims
- 1297US11839599B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted Dec 12, 2023·2 cites·26 claims
- 1397US11779554B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Oct 10, 2023·2 cites·18 claims
- 1496US11793776B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Oct 24, 2023·2 cites·24 claims
- 1596US11648232B2Methods and compositions for treating excessive sleepinessAXSOME MALTA LTD·Filed 2021·Granted May 16, 2023·14 cites·16 claims
- 1693US12064411B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Aug 20, 2024·1 cites·18 claims
- 1793US11497725B2Treatment for obesityAXSOME MALTA LTD·Filed 2020·Granted Nov 15, 2022·2 cites·14 claims
- 1893US11439597B2Formulations of (R)-2-amino-3-phenylpropyl carbamateAXSOME MALTA LTD·Filed 2021·Granted Sep 13, 2022·2 cites·18 claims
- 1991US2025108030A1Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 2090US2025059135A1Treatment of cataplexyAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 2189US12390419B2Formulations of (R)-2-amino-3-phenylpropyl carbamateAXSOME MALTA LTD·Filed 2024·Granted Aug 19, 2025·0 cites·15 claims
- 2289US12194016B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2024·Granted Jan 14, 2025·0 cites·11 claims
- 2389US11986454B1Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Granted May 21, 2024·0 cites·23 claims
- 2489US2025059136A1Carbamoyl phenylalaninol compounds and uses thereofAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 2588US12263145B2Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2024·Granted Apr 1, 2025·0 cites·26 claims
- 2688US2025352476A1Formulations of (r)-2-amino-3-phenylpropyl carbamateAXSOME MALTA LTD·Filed 2025·Application pending·0 cites
- 2788US2025114322A1Methods and compositions for treating excessive sleepinessAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 2887US12162821B2Treatment of cataplexyAXSOME MALTA LTD·Filed 2023·Granted Dec 10, 2024·0 cites·20 claims
- 2986US11865098B1Methods and compositions for treating excessive sleepinessAXSOME MALTA LTD·Filed 2023·Granted Jan 9, 2024·0 cites·28 claims
- 3086US2024018098A1Carbamoyl Phenylalaninol Compounds and Uses ThereofAXSOME MALTA LTD·Filed 2023·Application pending·0 cites
- 3186US2024189270A1Methods and compositions for treating excessive sleepinessAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 3286US2024180866A1Methods and compositions for treating excessive sleepinessAXSOME MALTA LTD·Filed 2023·Application pending·0 cites
- 3385US12201601B2Treatment for obesityAXSOME MALTA LTD·Filed 2022·Granted Jan 21, 2025·0 cites·24 claims
- 3485US12102609B2Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Oct 1, 2024·0 cites·26 claims
- 3585US2025340509A1Compositions comprising (r)-2-amino-3-phenylpropyl carbamate and uses thereofAXSOME MALTA LTD·Filed 2025·Application pending·0 cites
- 3684US2025017890A1Carbamoyl phenylalaninol analogs and uses thereofAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 3783US11998639B2Formulations of (R)-2-amino-3-phenylpropyl carbamateAXSOME MALTA LTD·Filed 2022·Granted Jun 4, 2024·0 cites·19 claims
- 3882US2025000825A1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 3979US12318362B2Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2021·Granted Jun 3, 2025·0 cites·11 claims
- 4079US11713292B2Treatment of cataplexyAXSOME MALTA LTD·Filed 2021·Granted Aug 1, 2023·0 cites·18 claims
- 4178US12384743B2Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereofAXSOME MALTA LTD·Filed 2022·Granted Aug 12, 2025·0 cites·7 claims
- 4278US11780805B2Carbamoyl phenylalaninol compounds and uses thereofAXSOME MALTA LTD·Filed 2021·Granted Oct 10, 2023·0 cites·18 claims
- 4376US2022401401A1Carbamoyl phenylalaninol analogs and uses thereofAXSOME MALTA LTD·Filed 2022·Application pending·0 cites
- 4475US2024041817A1Methods of providing solriamfetol therapy to subjects with impaired renal functionAXSOME MALTA LTD·Filed 2023·Application pending·0 cites
- 4570US12005036B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Jun 11, 2024·0 cites·30 claims
- 4670US11560354B2Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereofAXSOME MALTA LTD·Filed 2020·Granted Jan 24, 2023·0 cites·8 claims
- 4769US12036194B1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Jul 16, 2024·0 cites·28 claims
- 4868US12090126B2Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2023·Granted Sep 17, 2024·0 cites·15 claims
- 4966US2024350435A1Methods of administering solriamfetol to lactating womenAXSOME MALTA LTD·Filed 2024·Application pending·0 cites
- 5064US2025032442A1Methods and compositions for treating cognitive impairmentAXSOME MALTA LTD·Filed 2022·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when AXSOME MALTA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →